300791 logo

Sirio Pharma Co., Ltd. Stock Price

SZSE:300791 Community·CN¥6.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

300791 Share Price Performance

CN¥0
-20.98 (-100.00%)
CN¥0
-20.98 (-100.00%)
Price CN¥0

300791 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Undervalued with excellent balance sheet and pays a dividend.

1 Risk
4 Rewards

Sirio Pharma Co., Ltd. Key Details

CN¥4.5b

Revenue

CN¥3.0b

Cost of Revenue

CN¥1.4b

Gross Profit

CN¥1.1b

Other Expenses

CN¥345.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 24, 2026
1.13
32.11%
7.76%
50.3%
View Full Analysis

About 300791

Founded
1993
Employees
2776
CEO
Peiqing Li
WebsiteView website
www.siriopharma.com

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China.

Recent 300791 News & Updates

Recent updates

No updates